Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Physical Biology

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine, Physics, Chemistry

• Identifiers
  DOI 10.1088/1478-3975/8/1/015014PMID 21301066PMCID PMC3209705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet shape change and spreading.

  2012cited by this paper
• Rational Design of an Ex Vivo Model of Thrombosis

  2010cited by this paper
• Spatial Distribution of Factor Xa, Thrombin, and Fibrin(ogen) on Thrombi at Venous Shear

  2010cited by this paper
• Laminin promotes coagulation and thrombus formation in a factor XII‐dependent manner

  2010cited by this paper
• The many faces of tissue factor

  2009cited by this paper
• Death by Committee: Organellar Trafficking and Communication in Apoptosis

  2009cited by this paper
• Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2

  2008cited by this paper
• The role of platelet activation in tumor metastasis

  2008cited by this paper
• Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?

  2007cited by this paper
• E‐selectin‐mediated dynamic interactions of breast‐and colon‐cancer cells with endothelial‐cell monolayers

  2006cited by this paper
• Surface exposure of phosphatidylserine in pathological cells

  2005cited by this paper
• Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

  2004cited by this paper
• The assembly of the factor X‐activating complex on activated human platelets

  2003cited by this paper
• The dynamics of thrombin formation.

  2003cited by this paper
• Thrombin interactions.

  2003cited by this paper
• Venous thromboembolism and occult malignancy.

  2001cited by this paper
• Prognosis of cancers associated with venous thromboembolism.

  2000cited by this paper
• Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.

  2000influential reference
• Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

  2000cited by this paper
• Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions.

  2000cited by this paper
• Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study.

  1999cited by this paper
• Role of thrombin receptor in breast cancer invasiveness

  1999cited by this paper
• Activation of tissue‐factor gene expression in breast carcinoma cells by stimulation of the RAF‐ERK signaling pathway

  1998cited by this paper
• Thrombin receptor overexpression in malignant and physiological invasion processes

  1998cited by this paper
• The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis.

  1997cited by this paper
• Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.

  1997cited by this paper
• Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction.

  1996cited by this paper
• Tissue factor expression correlates with histological grade in human pancreatic cancer

  1995cited by this paper
• Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.

  1992cited by this paper
• Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes.

  1991cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma.

  1989cited by this paper
• Tissue culture studies on pleural effusions from breast carcinoma patients.

  1974cited by this paper
• Phlegmasia alba dolens.

  year unknowncited by this paper

• Membrane-Dependent Reactions of Blood Coagulation: Classical View and State-of-the-Art Concepts

  2024cites this paper
• Advances in the Study of Coagulation Function and Urologic Tumors

  2023cites this paper
• Lipid Transporters Beam Signals from Cell Membranes

  2021cites this paper
• Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo

  2020cites this paper
• The role of coagulation and platelets in colon cancer-associated thrombosis.

  2019cites this paper
• The role of tissue factor in metastasising, neoangiogenesis and hemostasis in cancer

  2019cites this paper
• A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.

  2019cites this paper
• The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation.

  2015cites this paper
• Study of the underlying mechanism of the hypercoagulable state in acute leukaemia and impact of specific treatments on the thrombotic risk

  2015cites this paper
• The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear.

  2015cites this paper
• Physical biology in cancer. 2. The physical biology of circulating tumor cells.

  2014cites this paper
• Interrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAs.

  2014cites this paper
• Study of the thrombogenicity induced by the cytotoxic treatment of malignant disease

  2014cites this paper
• Essentials of circulating tumor cells for clinical research and practice.

  2013cites this paper
• Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles

  2013cites this paper
• Physical parameters for the procoagulation phenotype of circulating cancer cells

  2013cites this paper
• Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide

  2013cites this paper
• Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor

  2013cites this paper
• c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade.

  2013cites this paper
• Modeling and Simulation of Procoagulant Circulating Tumor Cells in Flow

  2012cites this paper
• Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors

  2012cites this paper
• Development of Coagulation Factor Probes for the Identification of Procoagulant Circulating Tumor Cells

  2012influential citation
• Do circulating tumor cells play a role in coagulation and thrombosis?

  2012cites this paper
• The role of carrier number on the procoagulant activity of tissue factor in blood and plasma

  2011cites this paper
• Metastatic Disease: Interactions Between Tumor Cells and Host Environment During Cancer Cell Spread

  2011cites this paper
• Thrombin, thrombus, thrombi mechanisms of thrombus formation under flow

  2010cites this paper